PATENT CLAIM ANALYSIS

Application Number: 15922863
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["607", "017000"]

Abstract:
A method for managing bradycardia through vagus nerve stimulation is provided. An implantable neurostimulator configured to deliver electrical therapeutic stimulation in both afferent and efferent directions of a patient's cervical vagus nerve is provided. An operating mode is stored, which includes parametrically defining a maintenance dose of the electrical therapeutic stimulation tuned to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. The maintenance dose is delivered via a pulse generator through a pair of helical electrodes via an electrically coupled nerve stimulation therapy lead independent of cardiac cycle. The patient's physiology is monitored, and upon sensing a condition indicative of bradycardia, the delivery of the maintenance dose is suspended. A progressively increasing amount of time is spent waiting via a controller and, upon sensing a condition indicative of an absence or termination of the bradycardia, a progressively increasing partial maintenance dose is delivered via the pulse generator.

Claim (Index 9):
A method for managing bradycardia, comprising the steps of:\n defining a dose of electrical therapeutic stimulation, wherein the electrical therapeutic stimulation comprises a pulsed electrical signal comprising:\n a signal ON time; \n a signal OFF time; \n an output current; \n a signal frequency; \n a pulse width; and \n a duty cycle defined by dividing the signal ON time by the sum of the signal ON time and signal OFF time; \n delivering the dose to a vagus nerve of a patient; monitoring the patient's physiology via a physiological sensor; upon sensing a condition indicative of bradycardia, suspending the delivery of the dose to the vagus nerve, comprising:\n initiating a delay; \n upon expiry of the delay, checking the patient's physiology via the physiological sensor; and \n upon sensing a condition indicative of an absence or termination of the bradycardia, delivering the dose at a partial duty cycle to the vagus nerve; \n upon sensing a condition indicative of a continued absence of bradycardia, increasing the duty cycle of the dose in response to the monitoring of the patient's physiology.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.92941
- Patent Class: 607.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13554656', '13673766', '15274919', '15706946', '13828486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7321738457929523
- 35 USC 102 Novelty (BERT): 0.5946202142181728
- Combined Prediction Score: 0.7184184826354745
- Mean Citation Score: 536.520622
- Max Citation Score: 592.7178299999998
- Similarity Product: 464.79996768899184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test